- Scheme Category:
- Equity Scheme >
- Sectoral/Thematic Funds
NAV: ₹ ↓ -0.02%
NAV chart
SMA (Simple Moving Average)
- 50 SMA
- 100 SMA
- 200 SMA
- 400 SMA
Returns
CAGR returns till date
CAGR returns of ITI Pharma and Healthcare Fund - Regular Plan - Growth Option and its peers as on 30 April, 2026| Name | YTD | 1D | 1W | 1M | 3M | 1Y | 3Y | 5Y | 7Y | 10Y |
|---|---|---|---|---|---|---|---|---|---|---|
| ITI Pharma and Healthcare Fund - Regular Plan - Growth Option | 1.78% | -0.02% | 1.27% | 8.1% | 8.47% | 0.32% | 19.54% | - | - | - |
| SBI HEALTHCARE OPPORTUNITIES FUND - REGULAR PLAN -GROWTH | 4.34% | 0.23% | 1.46% | 5.71% | 8.21% | 4.56% | 24.91% | 15.57% | 20.11% | 12.33% |
| SBI ESG Exclusionary Strategy Fund - Regular Plan - Growth | -6.52% | -0.85% | -1.82% | 9.73% | -3.47% | 0.77% | 12.26% | 11.31% | 11.77% | 12.07% |
| SBI INFRASTRUCTURE FUND - REGULAR PLAN - GROWTH | 2.05% | -0.72% | 0.54% | 16.66% | 6.07% | 6.18% | 21.02% | 21.19% | 18.87% | 16.1% |
| SBI PSU Fund - REGULAR PLAN -Growth | 5.55% | -1.29% | -1.52% | 9.81% | 2.78% | 16.42% | 30.87% | 26.93% | 19.71% | 15.56% |
| SBI CONSUMPTION OPPORTUNITIES FUND - REGULAR - GROWTH | -5.46% | -0.83% | -1.06% | 10.77% | 1.03% | -4.44% | 11.24% | 15.49% | 13.84% | 14.51% |
Discrete returns (yearly)
| Year | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Returns | - | - | - | - | - | - | -8.89% | 32.42% | 41.76% | -10.78% |
Discrete returns (monthly)
| Month | Jul 2025 | Aug 2025 | Sep 2025 | Oct 2025 | Nov 2025 | Dec 2025 | Jan 2026 | Feb 2026 | Mar 2026 | Apr 2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| Returns | 2.32% | -1.92% | -1.63% | 2.13% | -1.19% | -2.59% | -6.96% | 6.8% | -4.76% | 7.57% |
Returns from spefic dates
| Description | CAGR returns from 26 Sep 2024 (Nifty 50 2024 high) |
|---|---|
| Returns | -3.68% |
Portfolio
Asset allocation
| Equity | Debt | Realestate | Commodities | Cash & Equivalents |
|---|---|---|---|---|
| 99.18% | 0.00% (Arbitrage: 0.00%) | 0.00% | 0.00% | 0.82% |
Equity
| Name | Symbol / ISIN | Sector | Weight % |
|---|---|---|---|
| Sun Pharmaceutical Industries Limited | SUNPHARMA (INE044A01036) | Pharmaceuticals & Biotechnology | 11.80% |
| Divi's Laboratories Limited | DIVISLAB (INE361B01024) | Pharmaceuticals & Biotechnology | 8.77% |
| Apollo Hospitals Enterprise Limited | APOLLOHOSP (INE437A01024) | Healthcare Services | 6.60% |
| Max Healthcare Institute Limited | MAXHEALTH (INE027H01010) | Healthcare Services | 5.50% |
| Torrent Pharmaceuticals Limited | TORNTPHARM (INE685A01028) | Pharmaceuticals & Biotechnology | 5.28% |
| Aurobindo Pharma Limited | AUROPHARMA (INE406A01037) | Pharmaceuticals & Biotechnology | 4.99% |
| Lupin Limited | LUPIN (INE326A01037) | Pharmaceuticals & Biotechnology | 4.20% |
| Laurus Labs Limited | LAURUSLABS (INE947Q01028) | Pharmaceuticals & Biotechnology | 3.65% |
| Alkem Laboratories Limited | ALKEM (INE540L01014) | Pharmaceuticals & Biotechnology | 3.12% |
| Fortis Healthcare Limited | FORTIS (INE061F01013) | Healthcare Services | 2.91% |
| Neuland Laboratories Limited | NEULANDLAB (INE794A01010) | Pharmaceuticals & Biotechnology | 2.66% |
| Aster DM Healthcare Limited | ASTERDM (INE914M01019) | Healthcare Services | 2.32% |
| Abbott India Limited | ABBOTINDIA (INE358A01014) | Pharmaceuticals & Biotechnology | 2.32% |
| Glenmark Pharmaceuticals Limited | GLENMARK (INE935A01035) | Pharmaceuticals & Biotechnology | 2.15% |
| Cohance Lifesciences Limited | COHANCE (INE03QK01018) | Pharmaceuticals & Biotechnology | 2.09% |
| Dr. Reddy's Laboratories Limited | DRREDDY (INE089A01031) | Pharmaceuticals & Biotechnology | 1.87% |
| Mankind Pharma Limited | MANKIND (INE634S01028) | Pharmaceuticals & Biotechnology | 1.85% |
| Sai Life Sciences Limited | SAILIFE (INE570L01029) | Pharmaceuticals & Biotechnology | 1.82% |
| IPCA Laboratories Limited | IPCALAB (INE571A01038) | Pharmaceuticals & Biotechnology | 1.70% |
| Cipla Limited | CIPLA (INE059A01026) | Pharmaceuticals & Biotechnology | 1.67% |
| Park Medi World Limited | INE119201023 | Healthcare Services | 1.49% |
| Linde India Limited | LINDEINDIA (INE473A01011) | Chemicals & Petrochemicals | 1.39% |
| Biocon Limited | BIOCON (INE376G01013) | Pharmaceuticals & Biotechnology | 1.29% |
| SBI Life Insurance Company Limited | SBILIFE (INE123W01016) | Insurance | 1.25% |
| Healthcare Global Enterprises Limited | HCG (INE075I01017) | Healthcare Services | 1.24% |
| Sumitomo Chemical India Limited | SUMICHEM (INE258G01013) | Fertilizers & Agrochemicals | 1.21% |
| FDC Limited | FDC (INE258B01022) | Pharmaceuticals & Biotechnology | 1.16% |
| Onesource Specialty Pharma Limited | ONESOURCE (INE013P01021) | Pharmaceuticals & Biotechnology | 1.15% |
| Rainbow Childrens Medicare Limited | RAINBOW (INE961O01016) | Healthcare Services | 1.11% |
| Shaily Engineering Plastics Limited | SHAILY (INE151G01028) | Consumer Durables | 1.11% |
| Piramal Pharma Limited | PPLPHARMA (INE0DK501011) | Pharmaceuticals & Biotechnology | 1.10% |
| Jubilant Ingrevia Limited | JUBLINGREA (INE0BY001018) | Chemicals & Petrochemicals | 1.06% |
| GlaxoSmithKline Pharmaceuticals Limited | GLAXO (INE159A01016) | Pharmaceuticals & Biotechnology | 1.00% |
| Orchid Pharma Limited | ORCHPHARMA (INE191A01027) | Pharmaceuticals & Biotechnology | 0.83% |
| Shilpa Medicare Limited | SHILPAMED (INE790G01031) | Pharmaceuticals & Biotechnology | 0.82% |
| Standard Engineering Technology Ltd | SGLTL (INE0M4D01010) | Industrial Manufacturing | 0.82% |
| Caplin Point Laboratories Limited | CAPLIPOINT (INE475E01026) | Pharmaceuticals & Biotechnology | 0.74% |
| Zydus Lifesciences Limited | ZYDUSLIFE (INE010B01027) | Pharmaceuticals & Biotechnology | 0.69% |
| AstraZeneca Pharma India Limited | ASTRAZEN (INE203A01020) | Pharmaceuticals & Biotechnology | 0.69% |
| Poly Medicure Limited | POLYMED (INE205C01021) | Healthcare Equipment & Supplies | 0.68% |
| Supriya Lifescience Limited | SUPRIYA (INE07RO01027) | Pharmaceuticals & Biotechnology | 0.67% |
| Syngene International Limited | SYNGENE (INE398R01022) | Healthcare Services | 0.41% |
Debt
| Name | Rating | Weight % |
|---|
Portfolio data is as on date 31 March, 2026
NAV history
ITI Pharma and Healthcare Fund - Regular Plan - Growth Option - 30 days NAV (Net asset value) history
| Date | NAV | % change |
|---|---|---|
| 30 April, 2026 | 15.9207 | -0.02% |
| 29 April, 2026 | 15.9238 | 0.09% |
| 28 April, 2026 | 15.9093 | -0.03% |
| 27 April, 2026 | 15.9139 | 2.4% |
| 24 April, 2026 | 15.5409 | -1.15% |
| 23 April, 2026 | 15.7213 | 1.35% |
| 22 April, 2026 | 15.5126 | 0.3% |
| 21 April, 2026 | 15.4663 | 0.06% |
| 20 April, 2026 | 15.4564 | -0.3% |
| 17 April, 2026 | 15.5023 | 0.63% |
| 16 April, 2026 | 15.4048 | 0.08% |
| 15 April, 2026 | 15.3927 | 1.68% |
| 13 April, 2026 | 15.1382 | -0.5% |
| 10 April, 2026 | 15.2149 | 0.98% |
| 9 April, 2026 | 15.0678 | 0.7% |
| 8 April, 2026 | 14.9629 | 1.27% |
| 7 April, 2026 | 14.7750 | 0.14% |
| 6 April, 2026 | 14.7545 | 0.43% |
| 2 April, 2026 | 14.6914 | -0.74% |
| 1 April, 2026 | 14.8010 | 0.5% |
| 31 March, 2026 | 14.7275 | -0.01% |
| 30 March, 2026 | 14.7284 | -1.53% |
| 27 March, 2026 | 14.9568 | -0.8% |
| 25 March, 2026 | 15.0767 | 1.6% |
| 24 March, 2026 | 14.8388 | 1.6% |
| 23 March, 2026 | 14.6054 | -2.29% |
| 20 March, 2026 | 14.9482 | 1.44% |
| 19 March, 2026 | 14.7361 | -2.4% |
| 18 March, 2026 | 15.0992 | 0.47% |
| 17 March, 2026 | 15.0283 |
FAQ (Frequently asked questions)
What is latest/current NAV/price of ITI Pharma and Healthcare Fund - Regular Plan - Growth Option?
The latest NAV of ITI Pharma and Healthcare Fund - Regular Plan - Growth Option is 15.9207 as on 30 April, 2026.What are YTD (year to date) returns of ITI Pharma and Healthcare Fund - Regular Plan - Growth Option?
The YTD (year to date) returns of ITI Pharma and Healthcare Fund - Regular Plan - Growth Option are 1.78% as on 30 April, 2026.What are 1 year returns of ITI Pharma and Healthcare Fund - Regular Plan - Growth Option?
The 1 year returns of ITI Pharma and Healthcare Fund - Regular Plan - Growth Option are 0.32% as on 30 April, 2026.What are 3 year CAGR returns of ITI Pharma and Healthcare Fund - Regular Plan - Growth Option?
The 3 year annualized returns (CAGR) of ITI Pharma and Healthcare Fund - Regular Plan - Growth Option are 19.54% as on 30 April, 2026.